Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wang's Baby-Health Pill (王氏保赤丸) is a traditional Chinese medicine (TCM) product developed by the Wang family during the Qing Dynasty and currently produced by Nantong Jidesheng, a subsidiary of Jinghua Pharmaceutical Group. It is formulated as micro-pills containing a blend of botanical extracts, including *Rheum palmatum* (rhubarb), *Coptis chinensis*, and *Inula helenium*. The medicine is primarily indicated for pediatric patients to treat digestive disorders such as dyspepsia, abdominal distension, and constipation, as well as associated symptoms like fever, vomiting, and diarrhea. It functions by promoting digestion, resolving food stagnation, and clearing internal heat, making it a staple in Chinese pediatric care for gastrointestinal regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wang's Baby-Health Pill.